Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors

Por Fischel, J-L, Formento, P, Milano, G
Publicado em 2005

Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.

Por Bernard, S., Etienne, M. C., Fischel, J. L., Formento, P., Milano, G.
Publicado em 1991

Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts

Por Bozec, A, Formento, P, Lassalle, S, Lippens, C, Hofman, P, Milano, G
Publicado em 2007

Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126

Por Bozec, A, Lassalle, S, Gugenheim, J, Fischel, J-L, Formento, P, Hofman, P, Milano, G
Publicado em 2006

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

Por Fischel, J-L, Rostagno, P, Formento, P, Dubreuil, A, Etienne, M-C, Milano, G
Publicado em 2001

Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancer

Por Magné, N, Fischel, J L, Dubreuil, A, Formento, P, Marcié, S, Lagrange, J-L, Milano, G
Publicado em 2002

Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity

Por Fischel, J L, Formento, P, Ciccolini, J, Rostagno, P, Etienne, M C, Catalin, J, Milano, G
Publicado em 2002

Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’)

Por Magné, N, Fischel, J L, Dubreuil, A, Formento, P, Poupon, M-F, Laurent-Puig, P, Milano, G
Publicado em 2002

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

Por Etienne, M. C., Bernard, S., Fischel, J. L., Formento, P., Gioanni, J., Santini, J., Demard, F., Schneider, M., Milano, G.
Publicado em 1991

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity

Por Etienne, M-C, Ilc, K, Formento, J-L, Laurent-Puig, P, Formento, P, Cheradame, S, Fischel, J-L, Milano, G
Publicado em 2004

Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil

Por Magné, N, Fischel, J-L, Tiffon, C, Formento, P, Dubreuil, A, Renée, N, Formento, J-L, Francoual, M, Ciccolini, J, Etienne, M-C, Milano, G
Publicado em 2003

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head an...

Por Etienne, M C, Pivot, X, Formento, J L, Bensadoun, R J, Formento, P, Dassonville, O, Francoual, M, Poissonnet, G, Fontana, X, Schneider, M, Demard, F, Milano, G
Publicado em 1999

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study

Por Etienne-Grimaldi, M-C, Mahamat, A, Chazal, M, Laurent-Puig, P, Olschwang, S, Gaub, M-P, Formento, J-L, Formento, P, Sudaka, A, Boige, V, Abderrahim-Ferkoune, A, Benchimol, D, André, T, Houry, S, Faucheron, J-L, Letoublon, C, Gilly, F-N, Delpero, J-R, Lasser, P, Pradere, B, Pezet, D, Penault-Llorca, F, Milano, G
Publicado em 2014